HomeCompareRMD vs EPD

RMD vs EPD: Dividend Comparison 2026

RMD yields 1.06% · EPD yields 5.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPD wins by $28.4K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
EPD
EPD
● Live price
5.57%
Share price
$39.08
Annual div
$2.18
5Y div CAGR
21.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.1K
Annual income
$9,876.61
Full EPD calculator →

Portfolio growth — RMD vs EPD

📍 EPD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDEPD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + EPD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
EPD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
EPD
Annual income on $10K today (after 15% tax)
$473.07/yr
After 10yr DRIP, annual income (after tax)
$8,395.12/yr
At 15% tax rate, EPD beats the other by $5,600.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + EPD for your $10,000?

RMD: 50%EPD: 50%
100% EPD50/50100% RMD
Portfolio after 10yr
$45.9K
Annual income
$6,582.43/yr
Blended yield
14.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPD right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
EPD
Analyst Ratings
35
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$35.86
-8.2% upside vs current
Range: $32.00 — $40.00
Altman Z
2.1
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
EPD buys
0
No recent congressional trades found for RMD or EPD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDEPD
Forward yield1.06%5.57%
Annual dividend / share$2.33$2.18
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%21.4%
Portfolio after 10y$31.7K$60.1K
Annual income after 10y$3,288.25$9,876.61
Total dividends collected$10.4K$34.2K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyBuy
Analyst price target$295.88$35.86

Year-by-year: RMD vs EPD ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrEPD PortfolioEPD Income/yrGap
1← crossover$10,844$143.91$11,376$675.65$532.00EPD
2$11,801$198.21$13,044$872.04$1.2KEPD
3$12,901$273.96$15,092$1,134.50$2.2KEPD
4$14,185$380.39$17,637$1,489.23$3.5KEPD
5$15,709$531.20$20,846$1,974.66$5.1KEPD
6$17,556$747.16$24,954$2,648.08$7.4KEPD
7$19,845$1,060.53$30,297$3,596.41$10.5KEPD
8$22,757$1,522.63$37,372$4,954.13$14.6KEPD
9$26,567$2,217.64$46,921$6,933.42$20.4KEPD
10$31,715$3,288.25$60,082$9,876.61$28.4KEPD

RMD vs EPD: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

EPDEnergy

Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services. It operates 19 natural gas processing facilities located in Colorado, Louisiana, Mississippi, New Mexico, Texas, and Wyoming; NGL pipelines; NGL fractionation facilities; NGL and related product storage facilities; and NGL marine terminals. The Crude Oil Pipelines & Services segment operates crude oil pipelines; and crude oil storage and marine terminals, which include a fleet of 255 tractor-trailer tank trucks that are used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates natural gas pipeline systems to gather, treat, and transport natural gas. It leases underground salt dome natural gas storage facilities in Napoleonville, Louisiana; owns an underground salt dome storage cavern in Wharton County, Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related marketing activities; butane isomerization complex and related deisobutanizer operations; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines and terminals; and ethylene export terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is headquartered in Houston, Texas.

Full EPD Calculator →
📬

Get this RMD vs EPD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.